Resources

First-in-class drug discovery: de novo design and lead optimization solutions for data-sparse targets
Avammune develops novel oncology therapeutics using multi-modal approaches that target hard-to-treat cancers with distinct biological mechanisms....
ACS Fall 2026 in Chicago
From cutting-edge research to first disclosures, Stuart Lang shares a snapshot of current advancements from his attendance at ACS Fall in Chicago...
1 / 261